Ron C J Schackmann

Years Active: 2022-2022
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Alison M Schram, Igor Odintsov, Madelyn Espinosa-Cotton, Inna Khodos, Whitney J Sisso, Marissa S Mattar, Allan J W Lui, Morana Vojnic, Sara H Shameem, Thrusha Chauhan, Jean Torrisi, Jim Ford, Marie N O'Connor, Cecile A W Geuijen, Ron C J Schackmann, Jeroen J Lammerts van Bueren, Ernesto Wasserman, Elisa De Stanchina, Eileen M O'Reilly, Marc Ladanyi, Alexander E Drilon, Romel Somwar
Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements. Cancer discovery 12 (5) (2022)

Ron C J Schackmann.css-eqlu8i{font-size:small;padding-left:4px;}